Literature DB >> 19698426

Serotonin-related, anxiety/aggression-driven, stressor-precipitated depression. A psycho-biological hypothesis.

H van Praag.   

Abstract

The concept of a 5-HT related, anxiety and/or aggression-driven, stressor-precipitated depression is formulated and discussed. It comprises the following elements. The 5-HT ergic disturbances found in some depressed individuals - and of them particularly lowered CSF 5-HIAA - are linked to the anxiety- and the aggression-components of the depressive sydrome. In this type of depression - called 5-HT related depression - dysregulation of anxiety and/or aggression are primordial and mood lowering is a derivative phenomenon. In other words this is a group of anxiety/aggression-driven depressions. The 5-HT ergic impairment in certain types of depression is a trait-phenomenon, ie, persists during remission. This disturbance makes the individual susceptable for perturbation of anxiety- and aggression-regulation. Anxiety and (overt or suppressed) anger, are core constituents of the stress-syndrome. Thus, the 5-HT ergic disturbance will induce a heightened sensitivity for stressful events, ie, the latter will induce more readily than normal, stress phenomena , among which anxiety and anger. The latter psychological features induce lowering of mood and thus "drive" the patient into a fullblown depression. Furthermore it is predicted that anxiolytics and serenics (ie, anti-aggressive drugs) that act via normalisation of 5-HT ergic circuits, will exert a antidepressant effect in 5-HT related depression, in addition to their therapeutic actions in anxiety disorders and states of increased aggressiveness, respectively. The exact nature of the 5-HT ergic impairment in 5-HT related depression has yet to be elucidated.

Entities:  

Year:  1996        PMID: 19698426     DOI: 10.1016/0924-9338(96)84782-1

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  7 in total

1.  The association between injustice perception and psychological outcomes in an inpatient spinal cord injury sample: the mediating effects of anger.

Authors:  Z Trost; W Scott; M T Buelow; L Nowlin; B Turan; A Boals; K R Monden
Journal:  Spinal Cord       Date:  2017-05-30       Impact factor: 2.772

2.  Crossroads of corticotropin releasing hormone, corticosteroids and monoamines. About a biological interface between stress and depression.

Authors:  H. M. Van Praag
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

3.  Depressive and aggressive responses to frustration: development of a questionnaire and its validation in a sample of male alcoholics.

Authors:  M Y Baars; M J Müller; B Gallhofer; P Netter
Journal:  Depress Res Treat       Date:  2011-03-17

4.  Clinical and physiological correlates of irritability in depression: results from the Netherlands study of depression and anxiety.

Authors:  Floor E A Verhoeven; Linda Booij; Nic J A Van der Wee; Brenda W H J Penninx; A J Willem Van der Does
Journal:  Depress Res Treat       Date:  2011-10-26

5.  Discriminating Suicide Attempters and Predicting Suicide Risk Using Altered Frontolimbic Resting-State Functional Connectivity in Patients With Bipolar II Disorder.

Authors:  Rongxin Zhu; Shui Tian; Huan Wang; Haiteng Jiang; Xinyi Wang; Junneng Shao; Qiang Wang; Rui Yan; Shiwan Tao; Haiyan Liu; Zhijian Yao; Qing Lu
Journal:  Front Psychiatry       Date:  2020-11-26       Impact factor: 4.157

Review 6.  Big effects of small RNAs: a review of microRNAs in anxiety.

Authors:  Stefanie Malan-Müller; Sîan Megan Joanna Hemmings; Soraya Seedat
Journal:  Mol Neurobiol       Date:  2012-11-13       Impact factor: 5.590

7.  During the long way to Mars: effects of 520 days of confinement (Mars500) on the assessment of affective stimuli and stage alteration in mood and plasma hormone levels.

Authors:  Yue Wang; Xiaolu Jing; Ke Lv; Bin Wu; Yanqiang Bai; Yuejia Luo; Shanguang Chen; Yinghui Li
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.